Recombinant human interferon α2b (Zhaoke Pharmaceutical)

重组人干扰素α2b（兆科药业）

Report date: 2022/11/02 14:05:27

Base Information

Drug NameRecombinant human interferon α2b (Zhaoke Pharmaceutical)
Drug Alias Name重组人干扰素α2b凝胶Interferon alpha-2b (Lee's Pharmaceutical)Recombinant Human Interferon α2b GelYallaferon
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsUterine Cervical IncompetenceUterine Cervical ErosionUterine Diseases +[9] 
Global Approved IndicationsUterine DiseasesHerpes ZosterHerpes Labialis +[5] 
Approved Indications in ChinaUterine DiseasesHerpes ZosterHerpes Labialis +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMongoliaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhaoke Pharmaceutical (Hefei) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMongolian National University Of Medical SciencesZhaoke Pharmaceutical (Hefei) Co Ltd
Inactive CompaniesLee'S Pharmaceutical Ltd
Active IndicationsUterine Cervical IncompetenceUterine Cervical ErosionUterine Diseases +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A